Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-29 · accession 0001773751-23-000191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-03 | 2023-06-29 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $2.43 | +23.3K | 23.3K | New | +$56.6K |
| D | 2023-07-03 | 2023-06-29 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale+OE | $9.02 | -23.3K | 0 | -100% | -$210.0K |
| D | 2023-07-03 | 2023-06-29 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $0.00 | -23.3K | 3.11M | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-29 | M | A | 23,282 | $2.43 | 23,282 | D | — | — | (F1) The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person. (F2) Shares of the Company were previously reported as directly beneficially owned, but all such shares were previously transferred to the Dudum Family Community Property Trust. |
| 2 | Common | Class A Common Stock | 2023-06-29 | S | D | 23,282 | $9.02 | 0 | D | — | — | (F1) The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person. (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2023-06-29 | M | D | 23,282 | $0.00 | 3,111,033 | D | $2.43 · — to 2030-06-17 | 23,282 Class A Common Stock | (F4) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. |